References
- Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology 2013;81:1159–1165.
- Wall M. Idiopathic intracranial hypertension (pseudotumor cerebri). Curr Neurol Neurosci Rep 2008;8:87–93.
- Wall M. Update on idiopathic intracranial hypertension. Neurol Clin 2017;35:45–57.
- Thurtell MJ, Bruce BB, Newman NJ, Biousse V. An update on idiopathic intracranial hypertension. Rev Neurol Dis 2010;7:e56–e68.
- Chen J, Wall M. Epidemiology and risk factors for idiopathic intracranial hypertension. Int Ophthalmol Clin 2014;54:1–11.
- Alder JB, Fraunfelder FT, Edwards R. Levonorgestrel implants and intracranial hypertension. N Engl J Med 1995;332:1720–1721.
- d’Arcangues C. Worldwide use of intrauterine devices for contraception. Contraception 2007;75:S2–S7.
- Altman DG, Gore SM, Gardner MJ, Pocock SJ. Statistical guidelines for contributors to medical journals. BMJ (Clin Res Ed) 1983;286:1489–1493.
- Wright SP. Adjusted P-values for simultaneous inference. Biometrics 1992;48:1005–1013.
- Wysowski DK, Green L. Serious adverse events in Norplant users reported to the Food and Drug Administration’s MedWatch Spontaneous Reporting System. Obstet Gynecol 1995;85:538–542.
- Sivin I. Comment: Serious adverse events in Norplant users reported to the Food and Drug Administration’s MedWatch Spontaneous Reporting System. Obstet Gynecol 1995;86:318–320
- Friedman DI, Jacobson DM. Idiopathic intracranial hypertension. J Neuroophthalmol 2004;24:138–145.
- Daniels AB, Liu GT, Volpe NJ, Galetta SL, Moster ML, Newman NJ, Biousse V, Lee AG, Wall M, Kardon R, Acierno MD, Corbett JJ, Maguire MG, Balcer LJ. Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol 2007;143:635–641.
- Glueck CJ, Aregawi D, Goldenberg N, Golnik KC, Sieve L, Wang P. Idiopathic intracranial hypertension, polycystic-ovary syndrome, and thrombophilia. J Lab Clin Med 2005;145:72–82.
- Campbell UB, Walker AM, Gaffney M, Petronis KR, Creanga D, Quinn S, Klein BE, Laties AM, Lewis M, Sharlip ID, Kolitsopoulos F, Klee BJ, Mo J, Reynolds RF. Acute nonarteritic anterior ischemic optic neuropathy and exposure to phosphodiesterase type 5 inhibitors. J Sex Med 2015;12:139–151.
- ACOG Practice Bulletin No. 121: Long-acting reversible contraception: implants and intrauterine devices. Obstet Gynecol 2011;118:184–196.
- Grimes DA, Schulz KF. Antibiotic prophylaxis for intrauterine contraceptive device insertionCochrane Database Syst Rev 2001;(2):CD001327.